Daiwa Securities Group’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-573
| Closed | -$2K | – | 1310 |
|
|
2025
Q4 | $2K | Hold |
573
| – | – | ﹤0.01% | 1310 |
|
|
2025
Q3 | $1K | Hold |
573
| – | – | ﹤0.01% | 1310 |
|
|
2025
Q2 | $0 | Hold |
573
| – | – | ﹤0.01% | 1321 |
|
|
2025
Q1 | $1K | Hold |
573
| – | – | ﹤0.01% | 1229 |
|
|
2024
Q4 | $3K | Sell |
573
-66,997
| -99% | -$272K | ﹤0.01% | 1196 |
|
|
2024
Q3 | $278K | Buy |
67,570
+11,800
| +21% | +$63.4K | ﹤0.01% | 926 |
|
|
2024
Q2 | $364K | Buy |
55,770
+4,900
| +10% | +$34.7K | ﹤0.01% | 889 |
|
|
2024
Q1 | $443K | Buy |
50,870
+48,397
| +1,957% | +$587K | ﹤0.01% | 863 |
|
|
2023
Q4 | $29K | Buy |
2,473
+1,900
| +332% | +$18.8K | ﹤0.01% | 1108 |
|
|
2023
Q3 | $6K | Hold |
573
| – | – | ﹤0.01% | 1143 |
|
|
2023
Q2 | $6K | Hold |
573
| – | – | ﹤0.01% | 1168 |
|
|
2023
Q1 | $6K | Hold |
573
| – | – | ﹤0.01% | 1139 |
|
|
2022
Q4 | $7K | Hold |
573
| – | – | ﹤0.01% | 1130 |
|
|
2022
Q3 | $6K | Hold |
573
| – | – | ﹤0.01% | 1155 |
|
|
2022
Q2 | $7K | Buy |
573
+95
| +20% | +$1.12K | ﹤0.01% | 1150 |
|
|
2022
Q1 | $6K | Hold |
478
| – | – | ﹤0.01% | 1158 |
|
|
2021
Q4 | $6K | Sell |
478
-80
| -14% | -$982 | ﹤0.01% | 1182 |
|
|
2021
Q3 | $7K | Buy |
558
+257
| +85% | +$3.32K | ﹤0.01% | 1158 |
|
|
2021
Q2 | $4K | Hold |
301
| – | – | ﹤0.01% | 1090 |
|
|
2021
Q1 | $3K | Hold |
301
| – | – | ﹤0.01% | 1108 |
|
|
2020
Q4 | $3K | Sell |
301
-584
| -66% | -$6.39K | ﹤0.01% | 1086 |
|
|
2020
Q3 | $8K | Hold |
885
| – | – | ﹤0.01% | 1057 |
|
|
2020
Q2 | $9K | Hold |
885
| – | – | ﹤0.01% | 1075 |
|
|
2020
Q1 | $9K | Hold |
885
| – | – | ﹤0.01% | 1066 |
|
|
2019
Q4 | $12K | Sell |
885
-98
| -10% | -$1.08K | ﹤0.01% | 1045 |
|
|
2019
Q3 | $8K | Hold |
983
| – | – | ﹤0.01% | 1044 |
|
|
2019
Q2 | $11K | Sell |
983
-191
| -16% | -$2.14K | ﹤0.01% | 1050 |
|
|
2019
Q1 | $11K | Buy |
1,174
+281
| +31% | +$3.14K | ﹤0.01% | 1030 |
|
|
2018
Q4 | $8K | Hold |
893
| – | – | ﹤0.01% | 1009 |
|
|
2018
Q3 | $14K | Hold |
893
| – | – | ﹤0.01% | 1013 |
|
|
2018
Q2 | $14K | Hold |
893
| – | – | ﹤0.01% | 1030 |
|
|
2018
Q1 | $12K | Buy |
+893
| New | +$11.1K | ﹤0.01% | 1018 |
|
Other funds holding IRWD
AC
SCM
VPM
VCM
Daiwa Securities Group's IRWD Position: Q1 2026 in Review
Daiwa Securities Group sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2026, closing a stake of 573 shares — an estimated $2K sold.
Daiwa Securities Group first reported a position in IRWD in Q1 2018 and held it in 32 quarters. The position peaked at $443K in Q1 2024. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.
- Daiwa Securities Group reported no remaining Ironwood Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Daiwa Securities Group sold 573 Ironwood Pharmaceuticals shares in Q1 2026, an estimated $2K.
- Daiwa Securities Group first reported a position in Ironwood Pharmaceuticals in Q1 2018 and held it in 32 quarters.
- Daiwa Securities Group's Ironwood Pharmaceuticals position peaked at $443K in Q1 2024.
- 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.
Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.